Current global research landscape on COVID-19 and cancer: Bibliometric and visualization analysis.
Bibliometric
COVID-19
Cancer
Coronavirus disease
Reference Citation Analysis
Scopus
VOSviewer
Journal
World journal of clinical oncology
ISSN: 2218-4333
Titre abrégé: World J Clin Oncol
Pays: United States
ID NLM: 101549149
Informations de publication
Date de publication:
24 Oct 2022
24 Oct 2022
Historique:
received:
30
04
2022
revised:
26
06
2022
accepted:
11
10
2022
entrez:
7
11
2022
pubmed:
8
11
2022
medline:
8
11
2022
Statut:
ppublish
Résumé
Cancer is a severe public health issue that seriously jeopardizes global health. In individuals with coronavirus disease 2019 (COVID-19), cancer is considered an independent risk factor for severe illness and increased mortality. To identify research hotspots and prospects, we used bibliometrics to examine the global production of COVID-19 literature published in the field of oncology. Data on publication output were identified based on the Scopus database between January 1, 2020, and June 21, 2022. This study used VOSviewer to analyze collaboration networks among countries and assess the terms most often used in the titles and abstracts of retrieved publications to determine research hotspots linked to cancer and COVID-19. The A total of 7015 publications were retrieved from the database. The United States published the greatest number of articles (2025; 28.87%), followed by Italy (964; 13.74%), the United Kingdom (839; 11.96%), and China (538; 7.67%). The This is the first bibliometric analysis to determine the present state and upcoming hot themes related to cancer and COVID-19 and vice versa using VOSviewer during the early stages of the pandemic. The emergence of hot themes related to cancer and COVID-19 may aid researchers in identifying new research areas in this field.
Sections du résumé
BACKGROUND
BACKGROUND
Cancer is a severe public health issue that seriously jeopardizes global health. In individuals with coronavirus disease 2019 (COVID-19), cancer is considered an independent risk factor for severe illness and increased mortality.
AIM
OBJECTIVE
To identify research hotspots and prospects, we used bibliometrics to examine the global production of COVID-19 literature published in the field of oncology.
METHODS
METHODS
Data on publication output were identified based on the Scopus database between January 1, 2020, and June 21, 2022. This study used VOSviewer to analyze collaboration networks among countries and assess the terms most often used in the titles and abstracts of retrieved publications to determine research hotspots linked to cancer and COVID-19. The
RESULTS
RESULTS
A total of 7015 publications were retrieved from the database. The United States published the greatest number of articles (2025; 28.87%), followed by Italy (964; 13.74%), the United Kingdom (839; 11.96%), and China (538; 7.67%). The
CONCLUSION
CONCLUSIONS
This is the first bibliometric analysis to determine the present state and upcoming hot themes related to cancer and COVID-19 and vice versa using VOSviewer during the early stages of the pandemic. The emergence of hot themes related to cancer and COVID-19 may aid researchers in identifying new research areas in this field.
Identifiants
pubmed: 36337308
doi: 10.5306/wjco.v13.i10.835
pmc: PMC9630994
doi:
Types de publication
Journal Article
Langues
eng
Pagination
835-847Informations de copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict-of-interest statement: All authors report no relevant conflict of interest for this article.
Références
Arch Public Health. 2021 Apr 13;79(1):49
pubmed: 33849636
BMC Infect Dis. 2020 Aug 1;20(1):561
pubmed: 32738881
Innovation (Camb). 2020 Aug 28;1(2):100027
pubmed: 32914141
JAMA Oncol. 2021 Aug 1;7(8):1113-1114
pubmed: 33983372
Int J Environ Res Public Health. 2021 Jan 22;18(3):
pubmed: 33499127
Lancet Public Health. 2020 Sep;5(9):e460
pubmed: 32888438
Nutr Cancer. 2022;74(2):450-462
pubmed: 34080508
Future Oncol. 2021 Jul;17(20):2631-2645
pubmed: 33880950
Oncologist. 2020 Jun;25(6):e936-e945
pubmed: 32243668
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
J Natl Compr Canc Netw. 2020 Mar 20;:1-4
pubmed: 32197238
Ann Oncol. 2020 Jul;31(7):894-901
pubmed: 32224151
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Infect Dis Poverty. 2020 Apr 7;9(1):34
pubmed: 32264957
Cancer Discov. 2020 Jun;10(6):783-791
pubmed: 32345594
Lancet. 2020 Jun 20;395(10241):1919-1926
pubmed: 32473682
Scientometrics. 2017;111(2):1053-1070
pubmed: 28490825
Front Cell Infect Microbiol. 2020 Sep 23;10:581404
pubmed: 33072630
BMC Public Health. 2019 May 22;19(1):625
pubmed: 31118003
Cancer Biol Med. 2021 Feb 15;18(1):298-307
pubmed: 33628602
Global Health. 2021 Mar 25;17(1):31
pubmed: 33766073
Lancet Oncol. 2020 May;21(5):622-624
pubmed: 32304634
JCO Glob Oncol. 2020 Sep;6:1428-1438
pubmed: 32986516
J Autoimmun. 2017 Dec;85:117-125
pubmed: 28728794
Asian Pac J Cancer Prev. 2021 May 01;22(5):1333-1349
pubmed: 34048161
Lancet. 2020 May 2;395(10234):1407-1409
pubmed: 32278362
Lancet. 2020 Jun 20;395(10241):1907-1918
pubmed: 32473681
Ann Transl Med. 2020 Jul;8(13):816
pubmed: 32793661
Medicine (Baltimore). 2020 Oct 23;99(43):e22849
pubmed: 33120818
BMJ Health Care Inform. 2021 Jan;28(1):
pubmed: 33419870
JAMA Oncol. 2020 Jul 1;6(7):1108-1110
pubmed: 32211820
Nat Rev Clin Oncol. 2020 May;17(5):268-270
pubmed: 32242095
Lung Cancer. 2021 Jul;157:60-65
pubmed: 33985850
Infect Dis Model. 2021;6:258-272
pubmed: 33458453
World J Gastroenterol. 2021 Apr 7;27(13):1341-1353
pubmed: 33833487
BMC Gastroenterol. 2019 Aug 30;19(1):158
pubmed: 31470803
Cancer Discov. 2020 Jul;10(7):935-941
pubmed: 32357994
Scientometrics. 2010 Aug;84(2):523-538
pubmed: 20585380
FASEB J. 2008 Feb;22(2):338-42
pubmed: 17884971
Lancet Oncol. 2020 Jul;21(7):904-913
pubmed: 32479787
Lancet Oncol. 2020 Aug;21(8):1023-1034
pubmed: 32702310
Environ Sci Pollut Res Int. 2021 May 6;:
pubmed: 33959839
Expert Rev Anticancer Ther. 2021 Sep;21(9):1055-1066
pubmed: 33970745
Clin Oncol (R Coll Radiol). 2021 Mar;33(3):e180-e191
pubmed: 33261978
World J Gastrointest Surg. 2021 Nov 27;13(11):1509-1522
pubmed: 34950437
World J Psychiatry. 2021 Jun 19;11(6):253-264
pubmed: 34168972
Nat Rev Clin Oncol. 2021 May;18(5):313-319
pubmed: 33723371
Lancet Oncol. 2021 Apr;22(4):411
pubmed: 33794199
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
Curr Oncol. 2006 Aug;13(4):119-20
pubmed: 17576451
BMJ Glob Health. 2021 May;6(5):
pubmed: 33972261
Lancet Oncol. 2021 Jun;22(6):738-739
pubmed: 34087120
In Vivo. 2020 Jun;34(3 Suppl):1613-1617
pubmed: 32503819
Int J Environ Res Public Health. 2020 Oct 21;17(20):
pubmed: 33096796
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
J Med Libr Assoc. 2018 Jan;106(1):81-86
pubmed: 29339937
Cureus. 2020 Mar 21;12(3):e7357
pubmed: 32328369
J Natl Cancer Inst. 2021 Apr 6;113(4):371-380
pubmed: 33136163
Risk Manag Healthc Policy. 2020 Sep 23;13:1711-1721
pubmed: 33061705
J Thorac Oncol. 2020 May;15(5):700-704
pubmed: 32114094
Environ Res. 2021 Nov;202:111637
pubmed: 34233155